Ipsogen, Sysmex Reach Distribution Deal | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – French molecular diagnostics firm Ipsogen today announced a distribution deal with Sysmex covering Japan.

Under the deal, Sysmex, based in Kobe, Japan, will distribute certain Ipsogen blood cancer products in Japan. Sysmex also will be responsible for the regulatory submission of Ipsogen products directed at the diagnosis and monitoring of BCR-ABL and JAK2 to Japanese health authorities. Sysmex has the exclusive rights to sell these products in Japan.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.